Spanish-Portuguese multicentre CIBELES study (Raul Moreno, Madrid, Spain) compared two drug-eluting stents – an everolimus (Xience V, Abbott Vascular, USA) and a sirolimus-releasing eluting stent (Cypher Select, Cordis Corporation, Miami Lakes, Florida, USA) in the context of total chronic coronary occlusions. With a non-inferiority design, the study randomized 208 patients (1:1), using as the primary endpoint a late loss in-stent at 9 months.
Conclusion: Xience stent proved to be non-inferior to Cypher stent in the context of total chronic occlusions.
Raúl Moreno
2012-05-17
